United States· US:83071-150_2ab47dd5-c8aa-0224-e063-6394a90acee4
Dr.Jucre Rebirth Sun Protection
A medicinal product containing octinoxate; homosalate; octisalate; avobenzone; ensulizole; octocrylene; bemotrizinol; niacinamide; adenosine, registered in United States by NATURECELL CO., LTD..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE; HOMOSALATE; OCTISALATE; AVOBENZONE; ENSULIZOLE; OCTOCRYLENE; BEMOTRIZINOL; NIACINAMIDE; ADENOSINE
- Manufacturer
- NATURECELL CO., LTD.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1183071150021 CONTAINER in 1 CARTON (83071-150-02) / 65 mL in 1 CONTAINER (83071-150-01)
- ndc1183071-150-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6a96dddd-31bc-418d-a32a-ff0433507545 GET /v1/drugs/6a96dddd-31bc-418d-a32a-ff0433507545?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "7.3; 6; 4.5; 4; 3.5; 2; 1.5; 2; .04",
"substance": "OCTINOXATE; HOMOSALATE; OCTISALATE; AVOBENZONE; ENSULIZOLE; OCTOCRYLENE; BEMOTRIZINOL; NIACINAMIDE; ADENOSINE",
"productndc": "83071-150",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about octinoxate; homosalate; octisalate; avobenzone; ensulizole; octocrylene; bemotrizinol; niacinamide; adenosine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.